Dr. Kassam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
196 Boston Ave
Suite #1000
Medford, MA 02155Phone+1 857-333-7375- Is this information wrong?
Education & Training
- University of Western OntarioClass of 2008
Certifications & Licensure
- NY State Medical License 2017 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 18 citationsEffectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study.Majdi Osman, Shrish Budree, Colleen R Kelly, Pratik Panchal, Jessica R Allegretti, Zain Kassam> ;Gastroenterology. 2022 Jul 1
- 2 citationsPilot study of autologous fecal microbiota transplants in nursing home residents: Feasibility and safety.Christine K Liu, Janet Seo, Vassiliki Pravodelov, Susan Frazier, Marsha Guy, Katherine Concilio, Rossana Lau-Ng, Gary Brandeis, Jon Watson, Jeannette van der Velde, Sc...> ;Contemporary Clinical Trials Communications. 2022 Jun 1
- 15 citationsStrain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis.Byron J Smith, Yvette Piceno, Martin Zydek, Bing Zhang, Lara Aboud Syriani, Jonathan P Terdiman, Zain Kassam, Averil Ma, Susan V Lynch, Katherine S Pollard, Najwa El-N...> ;Scientific Reports. 2022 Apr 1
- Join now to see all
Press Mentions
- Finch Therapeutics Presents Positive Data from PRISM3 Clinical Trial of CP101 for Recurrent C. Difficile at American College of Gastroenterology Annual Scientific MeetingOctober 25th, 2021
- VIDEO: COVID-19 Pandemic Presents Challenges to FMT TherapyMarch 24th, 2021
- Finch Therapeutics Presents Data from Its Positive PRISM3 Trial of CP101 in Recurrent C. Difficile Infection at Two Leading Medical ConferencesOctober 28th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: